首页> 外文期刊>Cell structure and function >Different Signalling Pathways are Used in the Commitment of Murine Erythroleukemia Cells (TSA8) to Differentiate, and in the Erythropoietin Action on Progenitor Cells
【24h】

Different Signalling Pathways are Used in the Commitment of Murine Erythroleukemia Cells (TSA8) to Differentiate, and in the Erythropoietin Action on Progenitor Cells

机译:不同的信号通路被用于小鼠红细胞白血病细胞(TSA8)的分化,并在促红细胞生成素对祖细胞的作用中

获取原文
           

摘要

References(15) The murine erythroleukemia (MEL) cell line, TSA8, becomes responsive to erythropoietin after induction with dimethyl sulfoxide (DMSO). We examined the signalling pathways involved in the commitment of TSA8 cells to become the erythroid progenitor cells responsive to erythropoietin, com-paring them with the pathway used in an erythropoietin-induced change of the progenitor cells.Amiloride, an inhibitor of the Na+/H+ antiporter, completely blocked the commitment of TSA8 cells to become responsive to erythropoietin at a concen-tration that did not affect cell proliferation, while it showed no effect on the differentiation or proliferation of the erythroid progenitor cells derived from TSA8 cells by erythropoietin. Ethyleneglycol-bis (β-aminoethyl ether) N, N, N', N'-tetra acetic acid (EGTA) inhibited the commitment of TSA8 cells to CFU-E-like cells without affecting colony formation. In contrast, EGTA did not inhibit erythropoietin-induced differentiation of the progenitor cells, but did inhibit their proliferation. These results indicate that erythropoietin uses different signalling pathways from those used in the induction of the commit-ment of TSA8 cells.
机译:参考文献(15)在用二甲基亚砜(DMSO)诱导后,鼠类红细胞白血病(MEL)细胞系TSA8对促红细胞生成素产生反应。我们检查了TSA8细胞参与成为促红细胞生成素反应的类红细胞祖细胞的信号通路,并将其与促红细胞生成素诱导的祖细胞变化的途径进行了比较.Amiloride是Na + / H +的抑制剂反转运蛋白以完全不影响细胞增殖的浓度完全阻断了TSA8细胞对促红细胞生成素作出反应的承诺,而对促红细胞生成素衍生自TSA8细胞的红系祖细胞的分化或增殖没有影响。乙二醇双(β-氨基乙基醚)N,N,N',N'-四乙酸(EGTA)抑制TSA8细胞对CFU-E样细胞的定型,而不会影响菌落的形成。相比之下,EGTA不会抑制促红细胞生成素诱导的祖细胞分化,但会抑制其增殖。这些结果表明促红细胞生成素使用与用于诱导TSA8细胞定型的信号转导途径不同的信号转导途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号